Vaccine Acceptance among Adults in Jalingo
Abstract
Vaccine acceptance is crucial to containing the most raging viral infections ravaging the world today. The COVID-19 vaccine is not an exception to this. COVID-19 vaccine acceptance is an issue of great concern all over the world, Nigeria inclusive; considering the manner the disease, COVID-19 ravaged the world, crumbled economies, and almost overwhelmed the healthcare delivery of every country. A cross-sectional study was adopted to determine the acceptance of the COVID-19 vaccine among adults aged 18-55 in Jalingo. The study was carried out among 420 Jalingo adult residents between June and November 2022. The pretested questionnaires were self-administered and collected on the spot. The results revealed that 61.1% of the adults in Jalingo accepted the COVID-19 vaccine. However, 61(33%) and 98(41.7%) of the male and female respondents, respectively, accepted it. While 13(68.40%),6(50%), 39(50.60%) and 101(32.40%) respondents of the age groups 46-55, 36-45, 26-35 and 18-25, respectively, accepted the vaccine, 11(78.60%) secondary school leavers, 4 (44.4%) and 68(33.20%) tertiary and primary school leavers accepted the vaccine. In the same vein, 76(39.60%) of the respondents who had no formal education (NFE) accepted the vaccine. However, factors like giving incentives, making the vaccine compulsory, providing substantial information on the vaccine, and making health professionals recommend it can influence the acceptance of the vaccine. The acceptance of the COVID-19 vaccine among adults in Jalingo was moderate. However, this acceptance rate can be improved upon if the encouraging factors are detected and efficiently utilised.
Downloads
References
Abay, E. S., Belew, M. D., Ketsela, B. S., Mengistu, E. E., Getachew, L. S., Teferi, Y. A., & Zerihun, A. B. (2022). Assessment of attitude towards COVID-19 vaccine and associated factors among clinical practitioners in Ethiopia: A cross-sectional study. Plos one, 17(6), e0269923. https://doi.org/10.1371/journal.pone.0269923
Ackah, B. B., Woo, M., Stallwood, L., Fazal, Z. A., Okpani, A., Ukah, U. V., & Adu, P. A. (2022). COVID-19 vaccine hesitancy in Africa: a scoping review. Global Health Research and Policy, 7(1), 1-20. https://doi.org/10.1186/s41256-022-00255-1
CDC Immunization. (2021). The Basics. CDC Immunization. https://www.cdc.gov/vaccines/vac-gen/imz-basics.htm
Cooper, S., Betsch, C., Sambala, E. Z., Mchiza, N., & Wiysonge, C. S. (2018). Vaccine hesitancy–a potential threat to the achievements of vaccination programmes in Africa. Human vaccines & immunotherapeutics, 14(10), 2355-2357. http:// doi: 10.1080/21645515.2018.1460987
El-Elimat, T., AbuAlSamen, M. M., Almomani, B. A., Al-Sawalha, N. A., & Alali, F. Q. (2021). Acceptance and attitudes toward COVID-19 vaccines: A cross-sectional study from Jordan. Plos one, 16(4), e0250555. https://doi.org/10.1371/journal.pone.0250555
El-Ghitany, E. M., Ashour, A., Omran, E. A., Farghaly, A. G., Hassaan, M. A., & Azzam, N. F. A. E. M. (2022). COVID-19 vaccine acceptance rates and predictors among the Egyptian general population and Healthcare workers, the intersectionality of age and other factors. Scientific Reports, 12(1), 19832. https://doi.org/10.1038/s41598-022-23825-
James, B. C., Ede, S. S., Aroh, C. M., Okoh, C. F., Kanokwan, C., Rasip, M. L., & Enbeyle, W. (2022). Attitudes and perceptions of Nigerians regarding receiving COVID-19 vaccines: an online cross-sectional study. The Pan African Medical Journal, 41. doi: 10.11604/pamj.2022.41.247.33286
Machado, B. A. S., Hodel, K. V. S., Fonseca, L. M. D. S., Mascarenhas, L. A. B., Andrade, L. P. C. D. S., Rocha, V. P. C., ... & Badaró, R. (2021). The importance of RNA-based vaccines in the fight against COVID-19: an overview. Vaccines, 9(11), 1345. doi: 10.3390/vaccines9111345.
Mustapha, M., Lawal, B. K., Sha’aban, A., Jatau, A. I., Wada, A. S., Bala, A. A., ... & Zainal, H. (2021). Factors associated with acceptance of COVID-19 vaccine among university health sciences students in Northwest Nigeria. PLoS One, 16(11), e0260672.https://doi.org/10.1371/journal.pone.0260672
Office of Infectious Disease and HIV/AIDS Policy (OIDP). (2022). Vaccine types. Office of Infectious Disease and HIV/AIDS Policy. https://www.hhs.gov/immunization/basics/types/index.html
VIPER Group COVID-19 Vaccine Tracker Team. (2022). Nigeria – COVID-19 Vaccine Tracker. VIPER Group. https://covid19.trackvaccines.org/country/nigeria/
US Department of Health and Human Services. (2022). Vaccine Types. US Department of Health and Human Services. https://www.hhs.gov/immunization/basics/types/index.html
VaccinesWork. (2022, November 8). What are viral vector-based vaccines and how could they be used against COVID-19? Gavi, the Vaccine Alliance. https://www.gavi.org/vaccineswork/what-are-viral-vector-based-vaccines-and-how-could-they-be-used-against-Covid-19
WHO. (2015, August 18). Vaccine hesitancy: A growing challenge for immunisation programmes. WHO. https://www.who.int/news/item/18-08-2015-vaccine-hesitancy-a-growing-challenge-for-immunization-programmes
Wu, L., Wang, X., Li, R., Huang, Z., Guo, X., Liu, J., ... & Sun, X. (2022). Willingness to receive a COVID-19 vaccine and associated factors among older adults: a cross-sectional survey in Shanghai, China. Vaccines, 10(5), 654. doi: 10.3390/vaccines10050654
Zintel, S., Flock, C., Arbogast, A. L., Forster, A., von Wagner, C., & Sieverding, M. (2022). Gender differences in the intention to get vaccinated against COVID-19: A systematic review and meta-analysis. Journal of Public Health, 1-25. doi: 10.1007/s10389-021-01677-w
Copyright (c) 2023 Modesta Ifeoma Mbah, PhD, Sumayyat Bakari Yero
This work is licensed under a Creative Commons Attribution 4.0 International License.
